Sponsor content
322 result(s) found, displaying 51 to 60
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort Respules Budesonide Suspension for Inhalation 2ml: 0.5mg.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort Respules Budesonide Suspension for Inhalation 2ml: 1mg.
-
Prescription medicine decision summaryTruqap (capivasertib), in combination with fulvestrant, is approved for the treatment of adult patients with locally advanced or metastatic breast cancer.
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort Respules budesonide 1 mg/2 mL.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort Respules budesonide 0.5 mg/2 mL.
-
Prescription medicine decision summaryLokelma (sodium zirconium cyclosilicate hydrate) was approved for the treatment of hyperkalaemia in adult patients. Lokelma binds to potassium in the gut and is used to treat high levels of potassium in the blood.
-
Prescription medicine registrationActive ingredients: dapagliflozin propanediol monohydrate, sitagliptin phosphate monohydrate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FELODIPINE AZN ER felodipine 10 mg extended release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FELODIPINE AZN ER felodipine 2.5 mg extended release tablet blister pack.